Pharmaceutical trademarks

Contrary to applicable practice in other countries such as the United States, Article 87 of the Mexican Industrial Property Law establishes that in Mexico, the right to obtain exclusive use of a mark is obtained through registration and not through use or priority adoption. Therefore, it is necessary to file an application before the Mexican Trademark Office (MTO), part of the Mexican Institute of Industrial Property (IMPI), complying with the requirements established by Article 113 of the law.